View in EDS

Identification of ribosomal protein eL21 as a novel externalized protein and a target in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Identification of ribosomal protein eL21 as a novel externalized protein and a target in triple-negative breast cancer.
Authors: Arnould L; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France., Radosevic-Robin N; Department of Pathology, Centre Jean Perrin, Platform for Advanced/Novel Tissue Analyses (TANYA), University Clermont Auvergne, INSERM U1240, 63011 Clermont-Ferrand, France., Duranton L; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France., Néri J; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Department of Translational Research and Innovation, Centre Léon Bérard, 69008 Lyon, France., Penault-Llorca F; Department of Pathology, Centre Jean Perrin, Platform for Advanced/Novel Tissue Analyses (TANYA), University Clermont Auvergne, INSERM U1240, 63011 Clermont-Ferrand, France., Diaz JJ; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France., Albaret MA; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France. marie.albaret@lyon.unicancer.fr.; Department of Translational Research and Innovation, Centre Léon Bérard, 69008 Lyon, France. marie.albaret@lyon.unicancer.fr., Catez F; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France. frederic.catez@lyon.unicancer.fr.
Source: Cancer gene therapy [Cancer Gene Ther] 2026 Apr; Vol. 33 (4), pp. 427-439. Date of Electronic Publication: 2026 Apr 09.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41957522
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Identification of ribosomal protein eL21 as a novel externalized protein and a target in triple-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Arnould+L%22">Arnould L</searchLink>; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Radosevic-Robin+N%22">Radosevic-Robin N</searchLink>; Department of Pathology, Centre Jean Perrin, Platform for Advanced/Novel Tissue Analyses (TANYA), University Clermont Auvergne, INSERM U1240, 63011 Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Duranton+L%22">Duranton L</searchLink>; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Néri+J%22">Néri J</searchLink>; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Department of Translational Research and Innovation, Centre Léon Bérard, 69008 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Penault-Llorca+F%22">Penault-Llorca F</searchLink>; Department of Pathology, Centre Jean Perrin, Platform for Advanced/Novel Tissue Analyses (TANYA), University Clermont Auvergne, INSERM U1240, 63011 Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Diaz+JJ%22">Diaz JJ</searchLink>; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Albaret+MA%22">Albaret MA</searchLink>; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France. marie.albaret@lyon.unicancer.fr.; Department of Translational Research and Innovation, Centre Léon Bérard, 69008 Lyon, France. marie.albaret@lyon.unicancer.fr.<br /><searchLink fieldCode="AU" term="%22Catez+F%22">Catez F</searchLink>; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France. frederic.catez@lyon.unicancer.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229432230%22">Cancer gene therapy</searchLink> [Cancer Gene Ther] 2026 Apr; Vol. 33 (4), pp. 427-439. <i>Date of Electronic Publication: </i>2026 Apr 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9432230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5500 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209291903%22">09291903 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Gene Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41957522
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41417-026-01026-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 427
    Titles:
      – TitleFull: Identification of ribosomal protein eL21 as a novel externalized protein and a target in triple-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Arnould L
      – PersonEntity:
          Name:
            NameFull: Radosevic-Robin N
      – PersonEntity:
          Name:
            NameFull: Duranton L
      – PersonEntity:
          Name:
            NameFull: Néri J
      – PersonEntity:
          Name:
            NameFull: Penault-Llorca F
      – PersonEntity:
          Name:
            NameFull: Diaz JJ
      – PersonEntity:
          Name:
            NameFull: Albaret MA
      – PersonEntity:
          Name:
            NameFull: Catez F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5500
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cancer gene therapy
              Type: main
ResultId 1